TY - JOUR
T1 - The burden of surgical site infections in Australia
T2 - A cost-of-illness study
AU - Royle, Ruth
AU - Gillespie, Brigid M.
AU - Chaboyer, Wendy
AU - Byrnes, Joshua
AU - Nghiem, Son
N1 - Publisher Copyright:
© 2023 The Author(s)
PY - 2023/5
Y1 - 2023/5
N2 - Objective: To estimate the cost of surgical site infections in Australian public hospitals in 2018–19, to demonstrate the economic burden of hospital-associated infection in a well-resourced health system. Methods: A cost-of-illness analysis was conducted over a 1-year time horizon based on data from published literature extrapolated using simulation techniques. The direct and indirect costs of SSI were estimated for Australia and each of its states and territories. Results: An estimated 16,541 cases of SSI occurred in Australian public hospitals in 2018–19, resulting in a total direct cost of A$323.5 million. The average cost per case was A$18,814, which was 2.5 times the average per capita spending on health. The indirect costs of absenteeism and premature death were valued at A$23.0 million and A$2 948.1 million per annum, respectively. Conclusion: SSI is a significant but preventable cost with most of the financial burden coming from premature deaths but underreporting means our costs are likely underestimated.
AB - Objective: To estimate the cost of surgical site infections in Australian public hospitals in 2018–19, to demonstrate the economic burden of hospital-associated infection in a well-resourced health system. Methods: A cost-of-illness analysis was conducted over a 1-year time horizon based on data from published literature extrapolated using simulation techniques. The direct and indirect costs of SSI were estimated for Australia and each of its states and territories. Results: An estimated 16,541 cases of SSI occurred in Australian public hospitals in 2018–19, resulting in a total direct cost of A$323.5 million. The average cost per case was A$18,814, which was 2.5 times the average per capita spending on health. The indirect costs of absenteeism and premature death were valued at A$23.0 million and A$2 948.1 million per annum, respectively. Conclusion: SSI is a significant but preventable cost with most of the financial burden coming from premature deaths but underreporting means our costs are likely underestimated.
KW - Adverse event
KW - Economic evaluation
KW - Hospital-associated infections
KW - Incidence
KW - Post-operative wound infection
KW - Surveillance
UR - http://www.scopus.com/inward/record.url?scp=85150807013&partnerID=8YFLogxK
U2 - 10.1016/j.jiph.2023.03.018
DO - 10.1016/j.jiph.2023.03.018
M3 - Article
SN - 1876-0341
VL - 16
SP - 792
EP - 798
JO - Journal of Infection and Public Health
JF - Journal of Infection and Public Health
IS - 5
ER -